Top Tech Companies (2,059)
Don't see your company?
Create a company profile
54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area
Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. The product is called RepliGut. It will allow drugs to be tested on an in vitro platform that more closely mimics native human biology. Our goal is to enable pharmaceutical companies to identify effective compounds earlier, before clinical trials; to reduce animal testing; and to make the drug development process faster, cheaper, and safer. Currently, 88% of drugs fail during clinical trials. Part of the reason is that during preclinical studies, drugs are tested using tumor cells and animals. These cannot accurately indicate the way that pharmaceuticals will behave in the human body. The current market lacks a viable method for testing drugs, prior to human testing, and RepliGut will more accurately reflect drug behavior in humans.
Genadyne Biotechnologies Inc. is a US and EU based developer and manufacturer of negative pressure wound therapy systems, wireless telemedicine solutions, wireless and wired weight scale systems and advance wound care dressings and topicals. The mission of Genadyne is to promote wound healing, decrease wound recurrence and maintain the dignity, independence, comfort and pain control of the wound care patient through our products and through education.
Applied Decision Science is based on Naturalistic Decision Making (NDM) theory.
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
Menopause research company offering digial communities, health tracking tech and synbiotics supplements including CBD.
Spira creates carbon negative materials from genetically engineered algae grown by a global network of farming partners to produce ingredients for food, cosmetic and textile companies.
Carmell Therapeutics Corporation is a privately-owned biotechnology company focused on the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs). These PBMs contain a concentration of natural regenerative factors that promote healing, reduce complications, and lead to healthcare savings.
.png)
OnePointOne is a mission-driven technology company founded on the reality that 1.1 billion people began this millennium hungry. To solve this problem, OnePointOne developed a fully automated vertical farming system to improve the health of humanity through plant-based foods and medicines. Using a patented aeroponic system, OnePointOne is able to quickly and sustainably grow the chemical-free, nutrient rich foods and revolutionary biopharmaceuticals needed to solve some of the world’s biggest challenges.
ECM Technologies is a Texas A&M University-based start-up.
Gilson provides high quality, dependable solutions for today's demanding liquid chromatography, solid phase extraction, liquid handling and gel permeation chromatography clean-up requirements. From the legendary PIPETMAN® products to a full range of system solutions, Gilson is the element of purification for your laboratory. Gilson has worldwide sales and service supporting the pharmaceutical, biotech, environmental, clinical, food & beverage and forensic markets. Our primary focus is on purifying samples via preparative HPLC, automated SPE or through GPC clean-up. Gilson focuses on early drug discovery and development with our preparative HPLC systems. Gilson's automated SPE systems and GPC clean-up systems support environmental, food & beverage, clinical and forensic markets performing a wide variety of clean-up applications. Headquartered in Middleton, Wisconsin, Gilson's innovative products will revolutionize the lab; providing the durability, flexibility, modularity and ease-of-use the industry has come to expect from Gilson. Gilson is an equal employment opportunity employer functioning under an affirmative action plan.
CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer genetic evaluations at point of care, and design a tailored cancer prevention plan - we can help healthcare systems get ahead of this costly and emotionally devastating disease.
A personalized medicine company and clinical laboratory focused on autoimmune neuropsychiatric disorders in children and adults.
Watershed Idea Foundry is an idea foundry created by Fountainhead Investment Partners that is focused on biomedical growth and innovation.
Bragg Peak Systems designs and manufactures medical and particle therapy planning and management systems.
Life Magnetics is commercializing a graphene based magnetic bead for RNA diagnostics, theraputics, and research.
AOA Dx is developing the next frontier in early-stage cancer detection through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglioside platform, GlycoLocate™, is paving the way for life-saving early cancer detection. In a first of its kind, AOA Dx has developed AKRIVIS GD™, an early-stage liquid biopsy test for ovarian cancer, that has proven excellent sensitivity and specificity in a recent study. We foresee novel tumor biomarker gangliosides as the future for diagnosis, prognosis, monitoring, and eventually targeted therapies across multiple cancers. AOA Dx was co-founded by three experts and passionate advocates of women’s health, who have worked together at two previous diagnostic startups, that both resulted in successful exits upon commercialization. AOA Dx, a Y combinator and VC backed company, raised an oversubscribed Seed Round to accelerate development and clinical studies. Awards & Accelerators: 1. Y Combinator 2. MassChallenge 3. Springboard Enterprises 4. MassMedic Ignite 5. Inc Magazine Top 100 Female Founders 6. Women's Health Innovation Summit Award 7. Massachusetts Life Sciences Center MassNextGen Award 8. The Wave Summit's Emerging Women Founder in Bio Award 9. The Eddies Award www.aoadx.com
Predicine is a global molecular insights company that is committed to advancing precision medicine in oncology and infectious diseases. Predicine has developed a breakthrough cell-free DNA- and cell-free RNA-based liquid biopsy technology enabling minimally invasive molecular diagnosis for treatment selection, therapy monitoring, and minimal residual disease and early cancer detection. The company has launched a portfolio of blood-, urine- and tissue-based diagnostic assays for oncology and infectious diseases, including COVID-19. Through its business operations in Silicon Valley, Houston, Shanghai, Singapore, Berlin and Boston, Predicine partners with leading biopharma companies, institutions and governments to support personalized healthcare on a global scale.
Iantech is a developer of a cataract treatment device.
